<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03598829</url>
  </required_header>
  <id_info>
    <org_study_id>18-004103</org_study_id>
    <nct_id>NCT03598829</nct_id>
  </id_info>
  <brief_title>A Prospective Clinical Trial Comparing Serum Mast Cell Tryptase (SMCT) Levels to Arthrofibrosis Rates Among Primary Total Knee Arthroplasty (TKA) Patients</brief_title>
  <official_title>A Prospective Clinical Trial Comparing Serum Mast Cell Tryptase (SMCT) Levels to Arthrofibrosis Rates Among Primary Total Knee Arthroplasty (TKA) Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research is being done to see if the amount of an enzyme in blood (called serum mast&#xD;
      cell tryptase) changes before and after surgery. The investigators would like to see if these&#xD;
      amounts are related to knee stiffness and pain in subjects that undergo a total knee&#xD;
      replacement.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">July 1, 2018</start_date>
  <completion_date type="Anticipated">July 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>SMCT values</measure>
    <time_frame>1 year</time_frame>
    <description>Serum mast tryptase values will be assessed post-operatively</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <condition>Arthropathy of Knee</condition>
  <condition>Arthrofibrosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Males or females between the ages of 20 to 100 years who are surgical candidates for&#xD;
        primary total knee replacement.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Investigators will include all patients with osteoarthritis who are surgical&#xD;
             candidates for primary TKA. Investigators will include all eligible male or female&#xD;
             patients between the ages of 20 years to 100 years old. All included study&#xD;
             participants must be able to give an informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant femoral or tibial deformity due to congenital or traumatic etiologies,&#xD;
             inflammatory arthritis, post-septic arthritis, osteomyelitis, prior infection of knee&#xD;
             joint, osteoporosis, dislocated or fragmented patella&#xD;
&#xD;
          -  Patients taking mast cell inhibitors and/or degranulation inhibitors for any reason.&#xD;
&#xD;
          -  The presence of infections, highly communicable diseases (e.g. AIDS), active&#xD;
             tuberculosis, venereal disease, hepatitis.&#xD;
&#xD;
          -  Significant neurological or musculoskeletal disorders or disease that may adversely&#xD;
             affect normal gait or weight bearing.&#xD;
&#xD;
          -  Presence of previous prosthetic knee replacement devices (of any type)&#xD;
&#xD;
          -  Metastatic disease&#xD;
&#xD;
          -  Psychiatric illness&#xD;
&#xD;
          -  Drug or alcohol abuse&#xD;
&#xD;
          -  Inability to participate in standard postoperative rehabilitation protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew Abdel, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 3, 2018</study_first_submitted>
  <study_first_submitted_qc>July 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2018</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Matthew P. Abdel, M.D.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

